Vaginal practices and associations with barrier methods and gel use among sub-saharan African women enrolled in an HIV prevention trial

AIDS and Behavior

Volumn 14, Issue 3, 2010, Pages 590-599

  Der Straten, Ariane Van ^a,b   Cheng, Helen ^a   Chidanyika, Agnes ^c,d   Bruyn, Guy De ^e   Padian, Nancy ^d  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Africa; Condoms; Female initiated methods; HIV prevention trials; Vaginal practices

Indexed keywords

AGENTS USED INTRAVAGINALLY;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CLINICAL TRIAL; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; PHASE 3 CLINICAL TRIAL; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTILIZATION REVIEW; VAGINAL LAVAGE;

ADMINISTRATION, INTRAVAGINAL; ADULT; AFRICA SOUTH OF THE SAHARA; CONDOMS; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PREGNANCY; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINAL DOUCHING; YOUNG ADULT;

EID: 77956873548     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9690-3     Document Type: Article

References (38)

1. Meyer L, Kuhn L, Stein Z, et al. Vaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epide-miological evidence and biological mechanisms. Lancet Infect Dis. 2005;5:786-94.
2. Brown JE, Brown RC. Traditional intravaginal practices and the heterosexual transmission of disease: a review. Sex Transm Dis. 2000;27(4):183-7.
3. Hilber MA, Chersich MF, van de Wijgert J, et al. Vaginal practices, microbicides and HIV: what do we need to know? (Editorial). Sex Transm Inf. 2008;83(7):505-8.
4. Hilber AM, Hull T, Preston-Whyte E, et al. A cross cultural study of vaginal practices and sexuality: implications for sexual health. Soc Sci Med. 2010;70(3):392-400.
5. Civic D, Wilson D. Dry sex in Zimbabwe and implications for condom use. Soc Sci Med. 1996;42(1):91-8.
6. Scorgie F, Kunene B, et al. In search of sexual pleasure and fidelity: vaginal practices in KwaZulu-Natal, South Africa. Cult Health Sex. 2009;11(3):267-83.
7. Braunstein S, Wijgert JVD. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing. J Women's Health. 2005;14(5):424-33.
8. Dallabetta G, Miotti P, Chiphangwi J, et al. Traditional vaginal agents: use and association with HIV infection in Malawain women. AIDS. 1995;9:293-7.
9. van de Wijgert JH, Mason PR, Gwanzura L, et al. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis. 2000;181(2):587-94.
10. Romano J, Malcolm R, Garg S, et al. Microbicide delivery: formulation technologies and Strategies. Curr Opin HIV AIDS. 2008;3(5):558-66.
11. Ballag S, Brache V, Mauck C, et al. A Phase 1 study of the functional performance, safety, and acceptability of the Buffer-Gel Duet. Contraception. 2008;77(2):130-7.
12. Ellertson C, Burns M. Re-examining the role of cervical barrier devices. Outlook. 2003;20(2):1-8.
13. Behets F, Van Damme K, Turner A, et al. Evidence-based planning of a randomized controlled trial on diaphragm use for prevention of sexually transmitted infections. Sex Transm Dis. 2008;35(3):238-42.
14. Behets F, Turner A, Van Damme K, et al. Vaginal microbicide and diaphragm use for sexually transmitted infection prevention: a randomized acceptability and feasibility study among high-risk women in Madagascar. Sex Transm Dis. 2008;35(9):818-26.
15. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007; 370(9583):251-61.
16. Montgomery ET, Cheng H, van der Straten A, et al. Acceptability and use of the diaphragm and Replens((R)) Lubricant Gel for HIV prevention in Southern Africa. AIDS Behav. 2009 [epub ahead of print].
17. van der Straten A, Shiboski S, Montgomery ET, et al. Patterns and predictors of adherence to diaphragm use in a Phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquire Immune Defic Syndr. 2009;50(4):419-26.
18. van der Straten A, Cheng H, Moore J, et al. The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav. 2009;13(3):564-72.
19. Cook LA, Nanda K, Grimes DA, et al. Diaphragm versus diaphragm with spermicides for contraception. Coch Database Syst Rev. 2003, Issue 1. Art. No.: CD002031.
20. Ramjee G, van der Straten A, Chipato T, et al. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One. 2008;3(10):3488.
21. Meyer L, Denny L, de Souza M, et al. Vaginal practices, HIV and other sexually transmitted diseases among South African women. Sex Transm Dis. 2004;31(3):174-9.
22. van de Wijgert J, Morrison C, Cornelisse P, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2008;48:203-10.
23. Mensch B, Hewett P, Abbot S, et al. Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. Presented at the International Conference for Microbicide, Delhi, India, 2008.
24. Buck J, Kang M, van der Straten A, et al. Barrier method preferences and perceptions among Zimbabwean women and their partners. AIDS Behav. 2005;9(4):415-22.
25. Okal J, Stadler J, et al. Secrecy, disclosure and accidental discovery: perspectives of diaphragm users in Mombasa, Kenya. Culture, Health & Sexuality. Int J Res Interv Care. 2008;10(1): 13-26.
26. Mantell JE, Morar NS, Myer L, Ramjee G. We have our protector: misperceptions of protection against HIV among participants in a microbicide efficacy trial. Am J Public Health. 2006; 96(6):1073-7.
27. Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol Med. 2010;17(1):99-111.
28. Veldhuijzen N, Nyinawabega J, Umulisa M, et al. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men. Cult Health Sex. 2006;8(5):395-406.
29. Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev. 2008;20(2):171-87.
30. Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health. 2004;94(7):1159-64.
31. Sharma A, Bukusi E, Posner S, et al. Sex preparation and diaphragm acceptability in sex work in Nairobi, Kenya. Sex Health. 2006;3(4):261-8.
32. van der Straten A. Intravaginal practices and diaphragm use in Zimbabwe (poster presentation). Paper presented at Microbicides Conference, Cape Town, South Africa, April 23-26, 2006.
33. Montgomery ET, Blanchard K, Cheng H, et al. Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa. Eur J Contracept Reprod Health Care. 2009;14(6):410-9.
34. Ray S, Gumbo N, Mbvizo M. Local voices: what some Harare men say about preparation for sex. Reprod Health Matters. 1996;7:34-45.
35. Bagnol B, Mariano E. Vaginal practices: eroticism and implications for women's health and condom use in Mozambique. Cult Health Sex. 2008;10(6):573-85.
36. Chersich M, Martin Hilber A, Schmidlin K, et al. Association between intravaginal practices and HIV acquisition in women: individual patient data meta-analysis of cohort studies in sub-Saharan Africa (oral presentation). International AIDS Society (IAS) Conference, Cape Town, SA, 2009.
37. Bentley ME, Morrow KM, Fullen A, et al. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect. 2000;32(4):1-5.
38. Coggins C, Blanchard K, Alvarez F, et al. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm Infect. 2000;76(6):480-3.